The Division of Infectious Diseases conducts research in several important areas from basic science to community health. Gene transfer strategies involving adenovectors and retrovectors are being employed to test the effects of neovascularization on implanted biosensor function in animal models. Studies of adaptive immunity and antigen presentation assist in the development of personalized tumor vaccines and cancer immunotherapy. The division collaborates with the Division of Immunology in evaluating impaired mycobacteria sensing by TLR2 and TLR4 polymorphic variants. We are actively engaged in programs that assess HIV-related medication adherence and promote favorable clinical  outcomes through longitudinal evaluations, including evaluating interventions such as contingency management strategies to ensure optimal health outcomes in this population.